Can dietary changes rapidly decrease cardiovascular mortality rates?

European Heart Journal

Volumn 32, Issue 10, 2011, Pages 1187-1189

  Capewell, Simon ^a   O'Flaherty, Martin ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET; DIETARY INTAKE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MORTALITY; NOTE; PRIORITY JOURNAL; THROMBOSIS;

AGE FACTORS; CARDIOVASCULAR DISEASES; DIET; HUMANS; LIFE STYLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS;

EID: 79957507088     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr049     Document Type: Note

References (24)

1. National Institute for Health and Clinical Excellence. Prevention of Cardiovascular Disease at Population Level. London: National Institute for Health and Clinical Excellence; 2010.
2. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP 3rd, Herderick EE, Cornhill JF. Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999;281:727-735. (Pubitemid 29113454)
3. Rose G. Incubation period of coronary heart disease. Int J Epidemiol 2005; 34:242.
4. Law M, Wald N, Stampfer M, Rimm E, Barker D, Mackenbach J, Kunst A. Why heart disease mortality is low in France: The time lag explanation. Br Med J 1999;318:1471.
5. Party M. Medical Research Council trial of treatment of hypertension in older adults: Principal results. BMJ 1992;304:405-412.
6. Mozaffarian D, Micha R,Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: A systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010;7:e1000252.
7. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
8. Meyers DG, Neuberger JS, He J. Cardiovascular effect of bans on smoking in public places: A systematic review and meta-analysis. J Am Coll Cardiol 2009;54: 1249-1255.
9. Franco M, Orduñez P, Caballero B, Tapia Granados JA, Lazo M, Bernal JL, Guallar E, Cooper RS. Impact of energy intake, physical activity, and populationwide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980- 2005. Am J Epidemiol 2007;166:1374-1380. (Pubitemid 350209043)
10. Uusitalo U, Feskens EJM, Tuomilehto J, Dowse G, Haw U, Fareed D, Hemraj F, Gareeboo H, Alberti K, Zimmet P. Fall in total cholesterol concentration over five years in association with changes in fatty acid composition of cooking oil in Mauritius: Cross sectional survey. Br Med J 1996;313:1044.
11. Puska P, Tuomilehto J, Nissinen A, Vartiainen E. The North Karelia Project 20 Years Results and Experiences. Helsinki: National Public Health Institute; 1995.
12. Strom A, Jensen R. Mortality from circulatory diseases in Norway 1940-1945. Lancet 1951;1:126-129.
13. Zatonski W, Campos H, Willett W. Rapid declines in coronary heart disease mortality in Eastern Europe are associated with increased consumption of oils rich in alpha-linolenic acid. Eur J Epidemiol 2008;23:3-10.
14. Leon DA, Shkolnikov VM, McKee M, Kiryanov N, Andreev E. Alcohol increases circulatory disease mortality in Russia: Acute and chronic effects or misattribution of cause? Int J Epidemiol 2010; doi:10.1093/ije/dyq102. Published online ahead of print 30 June 2010.
15. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355:675-687. (Pubitemid 30107623)
16. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
17. Wallace S, Mozaffarian D. Trans-fatty acids and nonlipid risk factors. Curr Atheroscler Rep 2009;11:423.
18. Brownell KD, Warner KE. The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q 2009;87:259-294.
19. Stender S, Dyerberg J, Bysted A, Leth T, Astrup A. A trans world journey. Atheroscler Suppl 2006;7:47-52. (Pubitemid 43831752)
20. He FJ, MacGregor GA. Reducing population salt intake worldwide: From evidence to implementation. Prog Cardiovasc Dis 2010;52:363-382.
21. Vos T, Carter R, Barendregt J, Mihalopoulos C, Veerman J, Magnus A, Cobiac L, Bertram M, Wallace A, ACE-Prevention Team. Assessing cost-effectiveness in prevention (ACE-prevention): Final report. Melbourne: University of Queensland, Brisbane and Deakin University; 2010.
22. Department of Health. Putting Prevention First. London: Department of Health; 2009. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicy AndGuidance/DH-083822 (20 July 2010).
23. Hardeman W, Griffin S, Johnston M, Kinmonth AL,Wareham NJ. Interventions to prevent weight gain: A systematic review of psychological models and behaviour change methods. Int J Obes 2000;24:131-143. (Pubitemid 30107560)
24. O'Flaherty M, Bishop J, Redpath A, McLaughlin T, Murphy D, Chalmers J, Capewell S. Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: Time trend study. BMJ 2009;339:b2613.